Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) Shares Outstanding (Weighted Average): 2011-2024

Historic Shares Outstanding (Weighted Average) for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $146.9 million.

  • Mimedx Group's Shares Outstanding (Weighted Average) rose 0.78% to $148.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $148.0 million, marking a year-over-year increase of 0.78%. This contributed to the annual value of $146.9 million for FY2024, which is 0.01% down from last year.
  • As of FY2024, Mimedx Group's Shares Outstanding (Weighted Average) stood at $146.9 million, which was down 0.01% from $147.0 million recorded in FY2023.
  • Mimedx Group's Shares Outstanding (Weighted Average)'s 5-year high stood at $147.0 million during FY2023, with a 5-year trough of $111.0 million in FY2020.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $135.9 million, with a median of $146.9 million in 2024.
  • In the last 5 years, Mimedx Group's Shares Outstanding (Weighted Average) grew by 29.29% in 2023 and then dropped by 0.01% in 2024.
  • Yearly analysis of 5 years shows Mimedx Group's Shares Outstanding (Weighted Average) stood at $111.0 million in 2020, then increased by 0.99% to $112.1 million in 2021, then grew by 1.36% to $113.7 million in 2022, then grew by 29.29% to $147.0 million in 2023, then decreased by 0.01% to $146.9 million in 2024.